Cargando…
Case report: Chlorpromazine and deep venous thrombosis
PURPOSE: Since the development of antipsychotic drugs in the 1950s, a variety of studies and case reports have been published that suggest an association between exposure to typical antipsychotics and venous thromboembolisms (VTE). Therefore, when starting treatment with antipsychotics, especially l...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Emerald Publishing Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364570/ https://www.ncbi.nlm.nih.gov/pubmed/32742621 http://dx.doi.org/10.1108/MIJ-10-2019-0005 |
_version_ | 1783559856077144064 |
---|---|
author | Reed, Matthew Joseph Comeau, Sean Wojtanowicz, Todd R. Sampathi, Bharat Reddy Penev, Sofia Bota, Robert |
author_facet | Reed, Matthew Joseph Comeau, Sean Wojtanowicz, Todd R. Sampathi, Bharat Reddy Penev, Sofia Bota, Robert |
author_sort | Reed, Matthew Joseph |
collection | PubMed |
description | PURPOSE: Since the development of antipsychotic drugs in the 1950s, a variety of studies and case reports have been published that suggest an association between exposure to typical antipsychotics and venous thromboembolisms (VTE). Therefore, when starting treatment with antipsychotics, especially low-potency typical antipsychotics and clozapine, health-care providers must account for the patient’s existing VTE risk factors. DESIGN/METHODOLOGY/APPROACH: In this case report, the authors describe the development of a pulmonary embolism associated with use of chlorpromazine in the treatment of an acute manic episode in a 51-year-old female patient with bipolar disorder type 1. FINDINGS: The patient was brought to the emergency room by the police on a legal hold for bizarre behaviors at a bus stop, which included incessantly yelling at bystanders. The patient was found to have disorganized thoughts, poor sleep, rapid speech, labile mood, distractibility, auditory hallucinations and grandiose delusions. During the course of her stay, the patient received extensive IM chlorpromazine for extreme agitation, in addition to chlorpromazine 200 mg IM Q8H, which was later decreased to chlorpromazine 100 mg chlorpromazine IM/PO Q8H. On day 4 of the treatment, the patient experienced difficulty breathing, hypoxia and tachycardia and was found to have bilateral expiratory wheezes. CT angiography showed sub-segmental pulmonary embolus and the patient was transferred to MICU service. The patient was then intubated and started on heparin by the medical team. Over the course of the next day, her respiratory distress resolved and the patient was extubated. ORIGINALITY/VALUE: It is possible that chlorpromazine may indeed increase VTEs, and there are various physiological postulations regarding the mechanism of action. However, multiple confounding variables existed in the authors’ report, including venous stasis and the use of restraints, tobacco and valproic acid. Each of these variables has been shown to increase VTE occurrence. Further controlled studies are necessary to identify the true relationship between antipsychotics and VTEs. |
format | Online Article Text |
id | pubmed-7364570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Emerald Publishing Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-73645702020-07-31 Case report: Chlorpromazine and deep venous thrombosis Reed, Matthew Joseph Comeau, Sean Wojtanowicz, Todd R. Sampathi, Bharat Reddy Penev, Sofia Bota, Robert Ment Illn Research Paper PURPOSE: Since the development of antipsychotic drugs in the 1950s, a variety of studies and case reports have been published that suggest an association between exposure to typical antipsychotics and venous thromboembolisms (VTE). Therefore, when starting treatment with antipsychotics, especially low-potency typical antipsychotics and clozapine, health-care providers must account for the patient’s existing VTE risk factors. DESIGN/METHODOLOGY/APPROACH: In this case report, the authors describe the development of a pulmonary embolism associated with use of chlorpromazine in the treatment of an acute manic episode in a 51-year-old female patient with bipolar disorder type 1. FINDINGS: The patient was brought to the emergency room by the police on a legal hold for bizarre behaviors at a bus stop, which included incessantly yelling at bystanders. The patient was found to have disorganized thoughts, poor sleep, rapid speech, labile mood, distractibility, auditory hallucinations and grandiose delusions. During the course of her stay, the patient received extensive IM chlorpromazine for extreme agitation, in addition to chlorpromazine 200 mg IM Q8H, which was later decreased to chlorpromazine 100 mg chlorpromazine IM/PO Q8H. On day 4 of the treatment, the patient experienced difficulty breathing, hypoxia and tachycardia and was found to have bilateral expiratory wheezes. CT angiography showed sub-segmental pulmonary embolus and the patient was transferred to MICU service. The patient was then intubated and started on heparin by the medical team. Over the course of the next day, her respiratory distress resolved and the patient was extubated. ORIGINALITY/VALUE: It is possible that chlorpromazine may indeed increase VTEs, and there are various physiological postulations regarding the mechanism of action. However, multiple confounding variables existed in the authors’ report, including venous stasis and the use of restraints, tobacco and valproic acid. Each of these variables has been shown to increase VTE occurrence. Further controlled studies are necessary to identify the true relationship between antipsychotics and VTEs. Emerald Publishing Limited 2019-11-04 /pmc/articles/PMC7364570/ /pubmed/32742621 http://dx.doi.org/10.1108/MIJ-10-2019-0005 Text en © Matthew Joseph Reed, Sean Comeau, Todd R. Wojtanowicz, Bharat Reddy Sampathi, Sofia Penev and Robert Bota. https://creativecommons.org/licenses/by/4.0/Published by Emerald Publishing Limited. This article is published under the Creative Commons Attribution (CC BY 4.0) licence. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this licence may be seen at: http://creativecommons.org/licences/by/4.0/legalcode (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Research Paper Reed, Matthew Joseph Comeau, Sean Wojtanowicz, Todd R. Sampathi, Bharat Reddy Penev, Sofia Bota, Robert Case report: Chlorpromazine and deep venous thrombosis |
title | Case report: Chlorpromazine and deep venous thrombosis |
title_full | Case report: Chlorpromazine and deep venous thrombosis |
title_fullStr | Case report: Chlorpromazine and deep venous thrombosis |
title_full_unstemmed | Case report: Chlorpromazine and deep venous thrombosis |
title_short | Case report: Chlorpromazine and deep venous thrombosis |
title_sort | case report: chlorpromazine and deep venous thrombosis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364570/ https://www.ncbi.nlm.nih.gov/pubmed/32742621 http://dx.doi.org/10.1108/MIJ-10-2019-0005 |
work_keys_str_mv | AT reedmatthewjoseph casereportchlorpromazineanddeepvenousthrombosis AT comeausean casereportchlorpromazineanddeepvenousthrombosis AT wojtanowicztoddr casereportchlorpromazineanddeepvenousthrombosis AT sampathibharatreddy casereportchlorpromazineanddeepvenousthrombosis AT penevsofia casereportchlorpromazineanddeepvenousthrombosis AT botarobert casereportchlorpromazineanddeepvenousthrombosis |